Ignite Creation Date:
2024-05-05 @ 11:30 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00067782
Status:
COMPLETED
Last Update Posted:
2011-04-14
First Post:
2003-08-27
Brief Title:
A Phase IIIB Study Evaluating the Effect on Serum Lipids Following a Switch to Atazanavir in HIV Infected Subjects Evidencing Virologic Suppression on Their First PI-Based Antiretroviral Therapy
Sponsor:
Bristol-Myers Squibb
Organization:
Bristol-Myers Squibb
Key Dates - Follows AllAPIJSON File Order
Start Date:
2002-12
Start Date Type:
None
Primary Completion Date:
2005-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2005-03
Completion Date Type:
ACTUAL
First Submit Date:
2003-08-27
First Submit QC Date:
August 27 2003
Study First Post Date:
2003-08-28
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2010-01-28
Disp First Submit QC Date:
January 28 2010
Disp First Post Date:
2010-02-01
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2011-04-07
Last Update Post Date:
2011-04-14
Last Update Post Date Type:
ESTIMATED